Xcell Therapeutics Statistics
Total Valuation
KOSDAQ:373110 has a market cap or net worth of KRW 40.75 billion. The enterprise value is 37.65 billion.
Market Cap | 40.75B |
Enterprise Value | 37.65B |
Important Dates
The last earnings date was Friday, March 28, 2025.
Earnings Date | Mar 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
KOSDAQ:373110 has 10.94 million shares outstanding. The number of shares has increased by 13.07% in one year.
Current Share Class | n/a |
Shares Outstanding | 10.94M |
Shares Change (YoY) | +13.07% |
Shares Change (QoQ) | +1.45% |
Owned by Insiders (%) | 17.72% |
Owned by Institutions (%) | 0.08% |
Float | 7.03M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 19.26 |
PB Ratio | 4.46 |
P/TBV Ratio | 4.75 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.94 |
EV / Sales | 19.46 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -5.10 |
Financial Position
The company has a current ratio of 2.14, with a Debt / Equity ratio of 0.63.
Current Ratio | 2.14 |
Quick Ratio | 1.90 |
Debt / Equity | 0.63 |
Debt / EBITDA | n/a |
Debt / FCF | -0.77 |
Interest Coverage | -2,119.47 |
Financial Efficiency
Return on equity (ROE) is -165.90% and return on invested capital (ROIC) is -49.18%.
Return on Equity (ROE) | -165.90% |
Return on Assets (ROA) | -42.63% |
Return on Invested Capital (ROIC) | -49.18% |
Return on Capital Employed (ROCE) | -77.86% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | 61 |
Asset Turnover | 0.14 |
Inventory Turnover | 4.44 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 4,378.60 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 28.26 |
Average Volume (20 Days) | 90,528 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KOSDAQ:373110 had revenue of KRW 1.93 billion and -9.54 billion in losses. Loss per share was -954.00.
Revenue | 1.93B |
Gross Profit | -1.40B |
Operating Income | -9.33B |
Pretax Income | -9.54B |
Net Income | -9.54B |
EBITDA | -7.68B |
EBIT | -9.33B |
Loss Per Share | -954.00 |
Balance Sheet
The company has 8.80 billion in cash and 5.70 billion in debt, giving a net cash position of 3.10 billion or 283.43 per share.
Cash & Cash Equivalents | 8.80B |
Total Debt | 5.70B |
Net Cash | 3.10B |
Net Cash Per Share | 283.43 |
Equity (Book Value) | 9.12B |
Book Value Per Share | 835.63 |
Working Capital | 5.61B |
Cash Flow
In the last 12 months, operating cash flow was -7.00 billion and capital expenditures -382.69 million, giving a free cash flow of -7.38 billion.
Operating Cash Flow | -7.00B |
Capital Expenditures | -382.69M |
Free Cash Flow | -7.38B |
FCF Per Share | -674.60 |
Margins
Gross Margin | -72.30% |
Operating Margin | -482.33% |
Pretax Margin | -493.35% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
KOSDAQ:373110 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -13.07% |
Shareholder Yield | -13.07% |
Earnings Yield | -23.42% |
FCF Yield | -18.11% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
KOSDAQ:373110 has an Altman Z-Score of -0.94. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.94 |
Piotroski F-Score | n/a |